Express Scripts settlement with FTC includes changes to insulin pricing practices and reshoring of rebate aggregator.
Browsing: Market Access
Updates on pricing, reimbursement, HTA decisions, and access policies affecting global healthcare markets.
FDA PreCheck program opens to pharmaceutical facilities aligning with national priorities, impacting AstraZeneca and Acadia drugs.
ACA subsidy alternative proposed by Crapo and Cassidy aims to enhance health savings accounts for bronze or catastrophic plans.
UK drug price deal allows the country to avoid US tariffs by adjusting pricing rules for new medicines.
UK drug price deal allows the country to avoid US tariffs by adjusting pricing rules for new medicines.
Medicare price negotiation reduces spending by 44% for Wegovy, Trelegy, and 13 other drugs, impacting 2027 prices.
Medicare price negotiation reduces costs by 44% for Wegovy, Trelegy, and 13 other drugs by 2027.
Medicare price negotiation establishes 2027 prices for Wegovy and Trelegy, reducing spending by 44% over 2024 list prices.
Medicare Drug Prices for 15 drugs unveiled, saving $8.5 billion, a 36% reduction.
South Africa compulsory license urged for HIV drug to enhance access and support WHO goals.